Reaction Details |
![](/images/Email.png) | Report a problem with these data |
Target | Prostaglandin E2 receptor EP4 subtype |
---|
Ligand | BDBM261795 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_1935411 (CHEMBL4481170) |
---|
IC50 | 6.1±n/a nM |
---|
Citation | Bäurle, S; Nagel, J; Peters, O; Bräuer, N; Ter Laak, A; Preusse, C; Rottmann, A; Heldmann, D; Bothe, U; Blume, T; Zorn, L; Walter, D; Zollner, TM; Steinmeyer, A; Langer, G Identification of a Benzimidazolecarboxylic Acid Derivative (BAY 1316957) as a Potent and Selective Human Prostaglandin E2 Receptor Subtype 4 (hEP4-R) Antagonist for the Treatment of Endometriosis. J Med Chem62:2541-2563 (2019) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Prostaglandin E2 receptor EP4 subtype |
---|
Name: | Prostaglandin E2 receptor EP4 subtype |
Synonyms: | PE2R4_HUMAN | PGE receptor EP4 subtype | PGE2 receptor EP4 subtype | PTGER2 | PTGER4 | Prostaglandin E2 receptor | Prostanoid EP4 receptor |
Type: | Enzyme |
Mol. Mass.: | 53134.53 |
Organism: | Homo sapiens (Human) |
Description: | P35408 |
Residue: | 488 |
Sequence: | MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCG
LAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLA
INHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTA
HAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRG
HPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQP
SLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSG
QHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPG
MGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSET
LNLSEKCI
|
|
|
BDBM261795 |
---|
n/a |
---|
Name | BDBM261795 |
Synonyms: | 3-[2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-1H-benzimidazol-5-yl]-1,2,4-oxadiazol-5(4H)-one | US9708311, 46 |
Type | Small organic molecule |
Emp. Form. | C26H23N5O3 |
Mol. Mass. | 453.4925 |
SMILES | CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)-c1noc(=O)[nH]1 |
Structure |
|